RE:RE:RE:market has over reacted according to this article So expect more downfall. Covid is ramping up and the markets can expect another shutdown. That will bring Medipharm down. There will be a tax loss sell off in December. Once Medipharms cash and assets start to dry up and they look to raise more capital to make sure the executive get paid. underwriters will short the shares and then cover with a bought issue. Hence the executives and institutions still make money and you the retail investors get another kick in the face. seen this happens way more than once Just take a look at the green organic Dutchmen glta